Abstract
The incidence of nephropathia epidemica (NE) was compared with the NE antibody prevalence in normal population in a highly endemic area of Sweden (Västerbotten county). The antibody prevalence rate in the oldest age groups were found to be 14 and 20 times higher than the accumulated life-risk of being hospitalized with NE for men and women respectively. Whether the infection in persons not admitted to hospital is subclinical, atypical or clinically fulminant, remains to be determined.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Niklasson B., Le Duc J. Isolation of the nephropathia epidemica agent in Sweden. Lancet. 1984 May 5;1(8384):1012–1013. doi: 10.1016/s0140-6736(84)92344-4. [DOI] [PubMed] [Google Scholar]
- Niklasson B., LeDuc J. W. Epidemiology of nephropathia epidemica in Sweden. J Infect Dis. 1987 Feb;155(2):269–276. doi: 10.1093/infdis/155.2.269. [DOI] [PubMed] [Google Scholar]